NCT02808741View on ClinicalTrials.gov

Evaluation of Immediate Release Tablet

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Invasive Aspergillosis
Interventions
DRUG

F901318 SDD

Pharmacokinetics area under curve

DRUG

F901318 IR

Pharmacokinetics area under curve

DRUG

F901318 IR Fasting

Pharmacokinetics area under curve

DRUG

F901318 IR Fed

Pharmacokinetics area under curve

Trial Locations (1)

Unknown

Quotient Clinical, Nottingham

Sponsors

Lead Sponsor

F2G Biotech GmbH

Collaborators (1)

Quotient Clinical
All Listed Sponsors
collaborator

Quotient Clinical

OTHER

lead

F2G Biotech GmbH

INDUSTRY

NCT02808741 - Evaluation of Immediate Release Tablet | Biotech Hunter | Biotech Hunter